Trial Profile
A phase 2b study of ABX-464 in HIV therapy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2018
Price :
$35
*
At a glance
- Drugs Obefazimod (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 10 Jul 2018 New trial record